Vascular Diseases  >>  Zontivity (vorapaxar)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zontivity (vorapaxar) / Merck (MSD)
NCT01358344: A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)

Completed
1
173
US
Pantoprazole, SCH 530348 (high percentage), SCH 530348 (standard percentage)
Merck Sharp & Dohme LLC
Acute Coronary Syndrome
12/10
12/10

Download Options